On the occasion of Pink October, the Franco-British Hospital is emphasizing the importance of oncogenetics in the management of breast cancer.
Avoid the occurrence of cancer
According to the National Cancer Institute (INCa), 5 to 10% of breast cancers are linked to a genetic anomaly. Thanks to advances in oncogenetics research, we are now able to better guide treatments, carry out early detection and even prevent the occurrence of cancer.
A global care pathway
It is a medical advance that is part of a global care pathway for people with breast or ovarian cancer, in particular, with the support of oncogenetics. The tests are carried out using a blood test taken at the Hospital.
Specific support
Results are obtained in 2 months. These are quick turnaround times for this type of exam. If a genetic anomaly is identified, specific support is then offered.
A risk prevention program
In the case of a patient suffering from cancer, her treatment may be adapted and a program to prevent the risk of developing other cancers (for example on the other breast or on the ovaries) can be included. In the case of a patient who does not have cancer, but who carries a genetic anomaly, we offer appropriate monitoring to detect the disease early or even prevent it through prophylactic surgery.
More information on www.hopitalfrancobritannique.org
 Didier Galibert
|
26/09/2023 | 
